カプトプリルとフルーセミドは,重度の薬剤耐性高血圧の治療に用いられる
Lancet (London, England)
|July 19, 1980
まとめ
カプトプリルとフルーセミドは,10人の患者の重度の耐性高血圧を効果的にコントロールしました. 一般的によく耐えるものの,この組み合わせ療法により,ほとんどの参加者の血カリウム濃度が大幅に上昇しました.
科学分野:
- 心臓病学 心臓病学
- 薬理学 薬理学とは
- ネフロロジーはネフロロジーを用います.
背景:
- 重度の耐火性高血圧は,心血管疾患に重大なリスクをもたらす.
- 加速した高血圧は,効果的な治療戦略の不可欠な必要性を示している.
研究 の 目的:
- 重度の耐性高血圧患者のフルーセミドと併用したカプトプリルの有効性と安全性を評価する.
- この組み合わせ療法が血圧制御と血濃度に与える影響を評価する.
主な方法:
- 制御不能の重度の高血圧 (平均動脈圧>140mmHg) を有する10人の患者からなるコホートを登録した.
- 患者は,カプトプリルとフルーセミドを含む治療レジメンを受けた.
- 血圧とプラズマカリウム濃度は,研究中ずっとモニタリングされていました.
主要な成果:
- 10人の患者全員が,カプトプリルとフルーセミドによる治療の後,血圧をコントロールすることができました.
- 10人の患者のうち9人は,有害な副作用を経験しなかった.
- プラズマカリウム濃度の有意な上昇は9人の患者 (1 mmol/l) で観察され,フルセミドの併用にもかかわらず3人が高カリミアを発症した.
結論:
- カプトプリルとフルーセミドの組み合わせは,重度の耐性高血圧の管理に高い有効性を示しています.
- この組み合わせ療法を使用する際には,高カリウム血症の危険性があるため,カリウムレベルを注意深くモニタリングすることが重要です.
関連する概念動画
Antihypertensive Drugs: Potassium-Sparing Diuretics
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...

